REGISTERED NUMBER: 08107543 (England and Wales)

Unaudited Financial Statements for the Year Ended 31st December 2024

for

Sterling Medical Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

Dr A Y M J Al-Memar

REGISTERED OFFICE:

Unit 1 College Fields

16 Prince George Road

Merton

London

SW19 2PT

REGISTERED NUMBER:

08107543 (England and Wales)

ACCOUNTANTS:

Sampson Fielding Ltd

34 - 35 Clarges Street

Mayfair

London

W1J 7EJ

FIXED ASSETS

Tangible assets

4

-

-

Investments

5

2,100

2,100

2,100

2,100

CURRENT ASSETS

Debtors

6

9,703

53,108

Cash at bank

6,912

10,596

16,615

63,704

CREDITORS

Amounts falling due within one year

7

335,270

333,247

NET CURRENT LIABILITIES

(318,655

)

(269,543

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(316,555

)

(267,443

)

CAPITAL AND RESERVES

Called up share capital

2

2

Retained earnings

(316,557

)

(267,445

)

(316,555

)

(267,443

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 26th September 2025 and were signed by:

Dr A Y M J Al-Memar - Director

1.	STATUTORY INFORMATION

Sterling Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

The financial statements are prepared in Pound Sterling which is the functional currency of the company and rounded to nearest pound.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

20% on cost

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through the profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Debtors and creditors receivable / payable within one year

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at the transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Going concern

The financial statements have been prepared on the going concern basis. The company is reliant on the support of its associated companies.

If ongoing support was to be withdrawn the company would be unable to continue in operational existence. Adjustments would then have to be made to reduce the balance sheet values of assets to their recoverable amounts and to provide for any further liabilities that may arise. The company is unable to quantify the effect of such adjustments on the financial statements.

The director believes that it is appropriate for the financial statements to be prepared on a going concern basis.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Computer

fittings

equipment

Totals

£

£

£

COST

At 1st January 2024

and 31st December 2024

1,170

11,932

13,102

DEPRECIATION

At 1st January 2024

and 31st December 2024

1,170

11,932

13,102

NET BOOK VALUE

At 31st December 2024

-

-

-

At 31st December 2023

-

-

-

5.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1st January 2024

and 31st December 2024

2,100

NET BOOK VALUE

At 31st December 2024

2,100

At 31st December 2023

2,100

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31/12/24

31/12/23

£

£

Trade debtors

9,703

8,578

Amounts owed by participating interests

-

44,530

9,703

53,108

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31/12/24

31/12/23

£

£

Trade creditors

1,401

2,401

Amounts owed to group undertakings

242,525

242,525

Taxation and social security

4,135

1,112

Other creditors

87,209

87,209

335,270

333,247